FDA’s inspection backlog: GAO raises concerns as delays mount

FDA’s inspection backlog: GAO raises concerns as delays mount

Source: 
RAPS.org
snippet: 

For decades, the Government Accountability Office (GAO) has raised concerns about the US Food and Drug Administration’s (FDA) inspections program. Now, a year after the agency halted most of its foreign and domestic inspections due to the COVID-19 pandemic, GAO warns that the ensuing backlog could take years to clear.